Journal: Cancer research
Article Title: Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer
doi: 10.1158/0008-5472.CAN-26-0493
Figure Lengend Snippet: A, Western blot analysis of Myc-CaP cells following 6-day treatment with DMSO, docetaxel (3.75μM), palbociclib (1μM), or PF-06873600 (500nM). B-C, Heatmaps displaying BCL2 ( B ) and IAP ( C ) family gene expression in Myc-CaP cells treated with DMSO, Nutlin-3 (10μM), palbociclib (1μM), T/P (25nM/1μM), PF-06873600 (500nM), alisertib (500nM), etoposide (500nM), or docetaxel (3.75μM) for 6 days from RNA-seq analysis (n=3/group). D, Representative clonogenic images of Myc-CaP cells pre-treated with DMSO or indicated drugs as in B , followed by replatement and treatment with ABT-263 (1μM) or DMSO for 48 hrs. Quantification of Crystal Violet staining is shown (n=3/group). E, Representative clonogenic images of Myc-CaP cells pre-treated with docetaxel for 6 days, followed by replatement and treatment with LCL161 (1μM), TNFα (160ng/ml), and/or Z-VAD (20μM) for 48 hrs. Quantification of Crystal Violet staining is shown (n=3/group). F, Western blot analysis of Myc-CaP cells pre-treated with docetaxel for 6 days, followed by replatement and treatment with DMSO, ABT-263, or LCL161/TNFα for 6 hrs. G, Quantification of clonogenic growth in Myc-CaP cells pre-treated with 3.75μM docetaxel for 6 days, followed by replatement and treatment with ABT-263 (1μM), LCL161 (1μM), TNFα (160ng/ml), MCC950 (1μM), and/or Nec-1 (10μM) for 48 hrs (n=3/group). H, Cytokine array analysis in Myc-CaP cells treated as in F . Data represent mean ± SEM. Statistical significance was determined by one-way ANOVA. NS, not significant.
Article Snippet: ABT-263 (Navitoclax; HY-10087, MedChemExpress) was dissolved in DMSO to yield 100 mM stock solutions and then diluted in corn oil (Sigma) to a final concentration of 5 mM prior to injecting into animals.
Techniques: Western Blot, Analysis, Gene Expression, RNA Sequencing, Staining